1 Introduction to Research & Analysis Reports
1.1 Antacids Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antacids Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antacids Overall Market Size
2.1 Global Antacids Market Size: 2022 VS 2029
2.2 Global Antacids Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Antacids Sales: 2018-2029
3 Company Landscape
3.1 Top Antacids Players in Global Market
3.2 Top Global Antacids Companies Ranked by Revenue
3.3 Global Antacids Revenue by Companies
3.4 Global Antacids Sales by Companies
3.5 Global Antacids Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Antacids Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Antacids Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antacids Players in Global Market
3.8.1 List of Global Tier 1 Antacids Companies
3.8.2 List of Global Tier 2 and Tier 3 Antacids Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Antacids Market Size Markets, 2022 & 2029
4.1.2 Non-Systemic Antacids
4.1.3 Systemic Antacids
4.2 By Type – Global Antacids Revenue & Forecasts
4.2.1 By Type – Global Antacids Revenue, 2018-2023
4.2.2 By Type – Global Antacids Revenue, 2024-2029
4.2.3 By Type – Global Antacids Revenue Market Share, 2018-2029
4.3 By Type – Global Antacids Sales & Forecasts
4.3.1 By Type – Global Antacids Sales, 2018-2023
4.3.2 By Type – Global Antacids Sales, 2024-2029
4.3.3 By Type – Global Antacids Sales Market Share, 2018-2029
4.4 By Type – Global Antacids Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antacids Market Size, 2022 & 2029
5.1.2 Rx Drug
5.1.3 OTC Drug
5.2 By Application – Global Antacids Revenue & Forecasts
5.2.1 By Application – Global Antacids Revenue, 2018-2023
5.2.2 By Application – Global Antacids Revenue, 2024-2029
5.2.3 By Application – Global Antacids Revenue Market Share, 2018-2029
5.3 By Application – Global Antacids Sales & Forecasts
5.3.1 By Application – Global Antacids Sales, 2018-2023
5.3.2 By Application – Global Antacids Sales, 2024-2029
5.3.3 By Application – Global Antacids Sales Market Share, 2018-2029
5.4 By Application – Global Antacids Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Antacids Market Size, 2022 & 2029
6.2 By Region – Global Antacids Revenue & Forecasts
6.2.1 By Region – Global Antacids Revenue, 2018-2023
6.2.2 By Region – Global Antacids Revenue, 2024-2029
6.2.3 By Region – Global Antacids Revenue Market Share, 2018-2029
6.3 By Region – Global Antacids Sales & Forecasts
6.3.1 By Region – Global Antacids Sales, 2018-2023
6.3.2 By Region – Global Antacids Sales, 2024-2029
6.3.3 By Region – Global Antacids Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Antacids Revenue, 2018-2029
6.4.2 By Country – North America Antacids Sales, 2018-2029
6.4.3 US Antacids Market Size, 2018-2029
6.4.4 Canada Antacids Market Size, 2018-2029
6.4.5 Mexico Antacids Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Antacids Revenue, 2018-2029
6.5.2 By Country – Europe Antacids Sales, 2018-2029
6.5.3 Germany Antacids Market Size, 2018-2029
6.5.4 France Antacids Market Size, 2018-2029
6.5.5 U.K. Antacids Market Size, 2018-2029
6.5.6 Italy Antacids Market Size, 2018-2029
6.5.7 Russia Antacids Market Size, 2018-2029
6.5.8 Nordic Countries Antacids Market Size, 2018-2029
6.5.9 Benelux Antacids Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Antacids Revenue, 2018-2029
6.6.2 By Region – Asia Antacids Sales, 2018-2029
6.6.3 China Antacids Market Size, 2018-2029
6.6.4 Japan Antacids Market Size, 2018-2029
6.6.5 South Korea Antacids Market Size, 2018-2029
6.6.6 Southeast Asia Antacids Market Size, 2018-2029
6.6.7 India Antacids Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Antacids Revenue, 2018-2029
6.7.2 By Country – South America Antacids Sales, 2018-2029
6.7.3 Brazil Antacids Market Size, 2018-2029
6.7.4 Argentina Antacids Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Antacids Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Antacids Sales, 2018-2029
6.8.3 Turkey Antacids Market Size, 2018-2029
6.8.4 Israel Antacids Market Size, 2018-2029
6.8.5 Saudi Arabia Antacids Market Size, 2018-2029
6.8.6 UAE Antacids Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Antacids Major Product Offerings
7.1.4 AstraZeneca Antacids Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Takeda Pharmaceutical
7.2.1 Takeda Pharmaceutical Company Summary
7.2.2 Takeda Pharmaceutical Business Overview
7.2.3 Takeda Pharmaceutical Antacids Major Product Offerings
7.2.4 Takeda Pharmaceutical Antacids Sales and Revenue in Global (2018-2023)
7.2.5 Takeda Pharmaceutical Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Antacids Major Product Offerings
7.3.4 Pfizer Antacids Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Reckitt Benckiser
7.4.1 Reckitt Benckiser Company Summary
7.4.2 Reckitt Benckiser Business Overview
7.4.3 Reckitt Benckiser Antacids Major Product Offerings
7.4.4 Reckitt Benckiser Antacids Sales and Revenue in Global (2018-2023)
7.4.5 Reckitt Benckiser Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Antacids Major Product Offerings
7.5.4 Bayer Antacids Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Procter & Gamble
7.6.1 Procter & Gamble Company Summary
7.6.2 Procter & Gamble Business Overview
7.6.3 Procter & Gamble Antacids Major Product Offerings
7.6.4 Procter & Gamble Antacids Sales and Revenue in Global (2018-2023)
7.6.5 Procter & Gamble Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Antacids Major Product Offerings
7.7.4 GlaxoSmithKline Antacids Sales and Revenue in Global (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Antacids Major Product Offerings
7.8.4 Johnson & Johnson Antacids Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 CONBA
7.9.1 CONBA Company Summary
7.9.2 CONBA Business Overview
7.9.3 CONBA Antacids Major Product Offerings
7.9.4 CONBA Antacids Sales and Revenue in Global (2018-2023)
7.9.5 CONBA Key News & Latest Developments
7.10 Xiuzheng Pharma
7.10.1 Xiuzheng Pharma Company Summary
7.10.2 Xiuzheng Pharma Business Overview
7.10.3 Xiuzheng Pharma Antacids Major Product Offerings
7.10.4 Xiuzheng Pharma Antacids Sales and Revenue in Global (2018-2023)
7.10.5 Xiuzheng Pharma Key News & Latest Developments
7.11 Sanofi
7.11.1 Sanofi Company Summary
7.11.2 Sanofi Antacids Business Overview
7.11.3 Sanofi Antacids Major Product Offerings
7.11.4 Sanofi Antacids Sales and Revenue in Global (2018-2023)
7.11.5 Sanofi Key News & Latest Developments
7.12 Bausch Health
7.12.1 Bausch Health Company Summary
7.12.2 Bausch Health Antacids Business Overview
7.12.3 Bausch Health Antacids Major Product Offerings
7.12.4 Bausch Health Antacids Sales and Revenue in Global (2018-2023)
7.12.5 Bausch Health Key News & Latest Developments
7.13 CR SANJIU
7.13.1 CR SANJIU Company Summary
7.13.2 CR SANJIU Antacids Business Overview
7.13.3 CR SANJIU Antacids Major Product Offerings
7.13.4 CR SANJIU Antacids Sales and Revenue in Global (2018-2023)
7.13.5 CR SANJIU Key News & Latest Developments
7.14 Novartis
7.14.1 Novartis Company Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Antacids Major Product Offerings
7.14.4 Novartis Antacids Sales and Revenue in Global (2018-2023)
7.14.5 Novartis Key News & Latest Developments
8 Global Antacids Production Capacity, Analysis
8.1 Global Antacids Production Capacity, 2018-2029
8.2 Antacids Production Capacity of Key Manufacturers in Global Market
8.3 Global Antacids Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antacids Supply Chain Analysis
10.1 Antacids Industry Value Chain
10.2 Antacids Upstream Market
10.3 Antacids Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antacids Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の制酸薬市場予測2023-2029：非全身性制酸薬、全身性制酸薬 |
| 【英語タイトル】Antacids Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5659 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：78 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の制酸薬市場規模と予測を収録しています。・世界の制酸薬市場：売上、2018年-2023年、2024年-2029年 ・世界の制酸薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の制酸薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「非全身性制酸薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 制酸薬のグローバル主要企業は、AstraZeneca、 Takeda Pharmaceutical、 Pfizer、 Reckitt Benckiser、 Bayer、 Procter & Gamble、 GlaxoSmithKline、 Johnson & Johnson、 CONBA、 Xiuzheng Pharma、 Sanofi、 Bausch Health、 CR SANJIU、 Novartisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、制酸薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の制酸薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の制酸薬市場：タイプ別市場シェア、2022年 ・非全身性制酸薬、全身性制酸薬 世界の制酸薬市場：用途別、2018年-2023年、2024年-2029年 世界の制酸薬市場：用途別市場シェア、2022年 ・一般用医薬品、一般用医薬品 世界の制酸薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の制酸薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における制酸薬のグローバル売上、2018年-2023年 ・主要企業における制酸薬のグローバル売上シェア、2022年 ・主要企業における制酸薬のグローバル販売量、2018年-2023年 ・主要企業における制酸薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 AstraZeneca、 Takeda Pharmaceutical、 Pfizer、 Reckitt Benckiser、 Bayer、 Procter & Gamble、 GlaxoSmithKline、 Johnson & Johnson、 CONBA、 Xiuzheng Pharma、 Sanofi、 Bausch Health、 CR SANJIU、 Novartis ************************************************************* ・調査・分析レポートの概要 制酸薬市場の定義 市場セグメント 世界の制酸薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の制酸薬市場規模 世界の制酸薬市場規模：2022年 VS 2029年 世界の制酸薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの制酸薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の制酸薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：非全身性制酸薬、全身性制酸薬 制酸薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：一般用医薬品、一般用医薬品 制酸薬の用途別グローバル売上・予測 ・地域別市場分析 地域別制酸薬市場規模 2022年と2029年 地域別制酸薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） AstraZeneca、 Takeda Pharmaceutical、 Pfizer、 Reckitt Benckiser、 Bayer、 Procter & Gamble、 GlaxoSmithKline、 Johnson & Johnson、 CONBA、 Xiuzheng Pharma、 Sanofi、 Bausch Health、 CR SANJIU、 Novartis ... |
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they’re also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
This report aims to provide a comprehensive presentation of the global market for Antacids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antacids. This report contains market size and forecasts of Antacids in global, including the following market information:
Global Antacids Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Antacids Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Antacids companies in 2022 (%)
The global Antacids market was valued at US$ 6399 million in 2022 and is projected to reach US$ 7955 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.
In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antacids manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antacids Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antacids Market Segment Percentages, by Type, 2022 (%)
Non-Systemic Antacids
Systemic Antacids
Global Antacids Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antacids Market Segment Percentages, by Application, 2022 (%)
Rx Drug
OTC Drug
Global Antacids Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antacids Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antacids revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Antacids revenues share in global market, 2022 (%)
Key companies Antacids sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Antacids sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter & Gamble
GlaxoSmithKline
Johnson & Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antacids, market overview.
Chapter 2: Global Antacids market size in revenue and volume.
Chapter 3: Detailed analysis of Antacids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antacids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antacids capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の制酸薬市場予測2023-2029：非全身性制酸薬、全身性制酸薬] (コード：MMG23JU5659)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の制酸薬市場予測2023-2029：非全身性制酸薬、全身性制酸薬]についてメールでお問い合わせ |
